Integra LifeSciences Holdings Corporation (Integra), a US based medical devices company, has appointed Christopher A. Thatcher as president of Integra NeuroSciences, effective March 3, 2009. In this role, Thatcher will be responsible for the management of Integra's foundational division and provide the strategic direction and leadership required to expand the already strong position enjoyed by the business.
Thatcher brings to Integra over 14 years of broad, global industry sector experience in medical devices, including implants, disposables and capital equipment markets. Thatcher comes to Integra following seven years at Bausch and Lomb, where he held positions of increasing responsibility, most recently as vice president, Americas and general manager of Bausch and Lomb’s Canadian Division. Thatcher significantly improved the performance of the Canadian business, while building a highly successful executive and management team. He established winning commercial strategies for five business units and restructured the various functional departments to improve commercial and financial success. Before joining Bausch and Lomb, Thatcher held several positions at Allergan’s Surgical Products division.
“We are delighted that Chris is joining our Integra team,” said Brian Larkin, group president, Integra LifeSciences Corporation. “He brings a wealth of general management experience that will help expand our business through the development of new strategies and dynamic commercial implementation.”
“I am honored to lead the Integra NeuroSciences group. Integra is experiencing significant growth and is very well positioned in the neurosurgical marketplace,” said Christopher Thatcher. “I look forward to working with Integra to continue our leadership position in neurosurgery and neuro critical care.”